The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 3, 2008, Pages 307-312

  Ozbey, Ulku ^a   Tug, Esra ^b   Kara, Murat ^a   Namli, Mustafa ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Cytokines; Interleukin 12B (p40) gene polymorphism; Neuropsychiatric disorders; Schizophrenia

Indexed keywords

DNA FRAGMENT; DNA POLYMERASE; INTERLEUKIN 12P40;

ADULT; ARTICLE; BLOOD; CONTROL GROUP; CORRELATION COEFFICIENT; DNA EXTRACTION; DNA FLANKING REGION; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA; TURKEY;

EID: 45149116696     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01798.x     Document Type: Article

References (33)

1. Strous RD, Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited. J. Autoimmun. 2006 27 : 71 80.
2. Mundo E, Altamura AC, Vismara S et al. MCP-1 gene (SCYA2) and schizophrenia: A case-control association study. Am. J. Med. Genet. B 2005 132 : 1 4.
3. Muller N, Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS, implications for psychiatric disorders. Prog. Neuropsychoph. 1998 22 : 1 33.
4. Sredni-Kenigsbuch D. TH1/TH2 cytokines in the central nervous system. Int. J. Neurosci. 2002 112 : 665 703.
5. Kim YK, Suh IB, Kim H et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs. Mol. Psychiatr. 2002 7 : 1107 1114.
6. Muller N, Riedel M, Ackenheil M, Schwarz MJ. The role of immune function in schizophrenia: An overview. Eur. Arch. Psychiatry Clin. Neurosci. 1999 249 : 62 68.
7. Yu L, Yang M, Zhao J et al. An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr. Res. 2004 71 : 179 183.
8. Gately MK, Renzetti LM, Magram J et al. The interleukin-12/ interleukin-12 receptor system: Role in normal and patho logic immune responses. Annu. Rev. Immunol. 1998 16 : 495 521.
9. Ma X, Aste-Amezaga M, Trinchieri G. Regulation of interleukin-12 production. Ann. N. Y. Acad. Sci 1996 795 : 13 25.
10. Maes M, Song C, Lin AH et al. Negative immunoregulatory effects of antidepressants: Inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999 20 : 370 379.
11. Picard C, Fieschi C, Altare F et al. Inherited Interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am. J. Hum. Genet. 2002 70 : 336 348.
12. Litjens NH, van der Plas MJ, Ravensbergen B et al. Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism. J. Invest. Dermatol. 2004 122 : 923 926.
13. Yilmaz V, Yentur SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokines 2005 30 : 188 194.
14. Fan JB, Tang JX, Gu NF et al. A familybased and case-control association study of the NOTCH4 gene and schizophrenia. Mol. Psychiatr. 2002 7 : 100 103.
15. Khoo SK, Hayden CM, Roberts M et al. Associations of the IL12B promoter polymorphism in longitudinal data from asthmatic patients 7-42 years of age. J. Allergy Clin. Immunol. 2004 113 : 475 481.
16. Morahan G, Huang D, Wu M et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002 360 : 455 459.
17. Reynard MP, Turner D, Navarrete V. Allele frequencies of polymorphisms of the tumour necrosis factor-α, interleukin-10, interferon γ and interleukin-2 genes in a North European Caucasoid group from the UK. Eur. J. Immunogenet. 2000 27 : 241.
18. Bagheri M, Abdi-Rad I, Omrani D, Khalkhali HR. Heterogeneity of cytokine single-nucleotide polymorphisms among the Iranian and in the other East-South Asian populations. Transfus. Med. 2006 16 : 192 199.
19. Gillessen S, Carvajal PD, Ling P et al. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur. J. Immunol. 1995 25 : 200 206.
20. Lin A, Kenis G, Bignotti S et al. The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6. Schizophr. Res. 1998 32 : 9 15.
21. Brett FM, Mizisin AP, Powell HC, Campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 1995 54 : 766 775.
22. Gaughran F, O'Neill E, Cole M, Collins K, Daly RJ, Shanahan F. Increased soluble interleukin 2 receptor levels in schizophrenia. Schizophr. Res. 1998 29 : 263 267.
23. Chen X, Wang X, Hossain S et al. Interleukin 3 and schizophrenia: The impact of sex and family history. Mol. Psychiatr. 2007 12 : 273 282.
24. Chen Q, Wang X, O'neill FA et al. Association study of CSF2RB with schizophrenia in Irish family and case - control samples. Mol. Psychiatr. 2007, 1 9.
25. Pae CU. Potential role of lymphotoxin-alpha (tumor necrosis factor-beta) in the development of schizophrenia. Med. Hypotheses 2007 68 : 1359 1362.
26. Watanabe Y, Nunokawa A, Kaneko N, Muratake T, Koizumi M, Someya T. Lack of association between the interleukin-1 gene complex and schizophrenia in a Japanese population. Psychiatry Clin. Neurosci. 2007 61 : 364 369.
27. Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav. Immun. 2006 20 : 532 545.
28. Watanabe Y, Muratake T, Kaneko N, Fukui N, Nara Y, Someya T. No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population. Psychiatry Res. 2007 153 : 1 6.
29. Pae CU, Serretti A, Artioli P et al. Interaction analysis between 5-HTTLPR and TNFA-238/-308 polymorphisms in schizophrenia. J. Neural. Transm. 2006 113 : 887 897.
30. Hall MA, McGlinn E, Coakley G et al. Genetic polymorphism of IL-12 p40 gene in immunemediated disease. Genes Immun. 2000 1 : 219 224.
31. Takahashi N, Akahoshi M, Matsuda A et al. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes. Hum. Mol. Genet. 2005 14 : 3149 3159.
32. Tsunemi Y, Saeki H, Nakamura K et al. Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci. 2002 30 : 161 166.
33. Morahan G, Huang D, Ymer SI et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat. Genet. 2001 27 : 218 221.